Remission of nephrotic-range albuminuria reduces risk of end-stage renal disease and improves survival in type 2 diabetic patients
- 17 September 2005
- journal article
- research article
- Published by Springer Science and Business Media LLC in Diabetologia
- Vol. 48 (11), 2241-2247
- https://doi.org/10.1007/s00125-005-1937-6
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Progression of nephropathy in type 2 diabetic patientsKidney International, 2004
- Improved survival in patients obtaining remission of nephrotic range albuminuria in diabetic nephropathyKidney International, 2004
- Albuminuria, a Therapeutic Target for Cardiovascular Protection in Type 2 Diabetic Patients With NephropathyCirculation, 2004
- Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: Lessons from RENAALKidney International, 2004
- Genetic Variation in the Renin-Angiotensin System and Progression of Diabetic NephropathyJournal of the American Society of Nephrology, 2003
- Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and NephropathyNew England Journal of Medicine, 2001
- Progression of diabetic nephropathyKidney International, 2001
- Remission of nephrotic range proteinuria in type I diabetesKidney International, 1994
- Enzyme immunoassay: an improved determination of urinary albumin in diabetics with incipient nephropathyScandinavian Journal of Clinical and Laboratory Investigation, 1985
- Radioimmunoassay for Urinary Albumin Using a Single AntibodyScandinavian Journal of Clinical and Laboratory Investigation, 1970